These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12754369)

  • 1. An Italian family affected by Nasu-Hakola disease with a novel genetic mutation in the TREM2 gene.
    Soragna D; Papi L; Ratti MT; Sestini R; Tupler R; Montalbetti L
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):825-6. PubMed ID: 12754369
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
    Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
    Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature.
    Montalbetti L; Soragna D; Ratti MT; Bini P; Buscone S; Moglia A
    Funct Neurol; 2004; 19(3):171-9. PubMed ID: 15595711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia.
    Sessa G; Podini P; Mariani M; Meroni A; Spreafico R; Sinigaglia F; Colonna M; Panina P; Meldolesi J
    Eur J Neurosci; 2004 Nov; 20(10):2617-28. PubMed ID: 15548205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.
    Bianchin MM; Lima JE; Natel J; Sakamoto AC
    Neurology; 2006 Feb; 66(4):615-6; author reply 615-6. PubMed ID: 16505336
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutations in TREM2 lead to pure early-onset dementia without bone cysts.
    Chouery E; Delague V; Bergougnoux A; Koussa S; Serre JL; Mégarbané A
    Hum Mutat; 2008 Sep; 29(9):E194-204. PubMed ID: 18546367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family.
    Numasawa Y; Yamaura C; Ishihara S; Shintani S; Yamazaki M; Tabunoki H; Satoh JI
    Eur J Neurol; 2011 Sep; 18(9):1179-83. PubMed ID: 21834902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis.
    Errichiello E; Dardiotis E; Mannino F; Paloneva J; Mattina T; Zuffardi O
    Front Immunol; 2019; 10():1685. PubMed ID: 31396216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease.
    Kuroda R; Satoh J; Yamamura T; Anezaki T; Terada T; Yamazaki K; Obi T; Mizoguchi K
    J Neurol Sci; 2007 Jan; 252(1):88-91. PubMed ID: 17125796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.
    Guerreiro R; Bilgic B; Guven G; Brás J; Rohrer J; Lohmann E; Hanagasi H; Gurvit H; Emre M
    Neurobiol Aging; 2013 Dec; 34(12):2890.e1-5. PubMed ID: 23870839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.
    Walter J
    J Biol Chem; 2016 Feb; 291(9):4334-41. PubMed ID: 26694609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasu-Hakola Disease.
    Samanci B; Ulukan Ç; Gündüz T; Kürtüncü M; Eraksoy M
    Neurol India; 2018; 66(1):263. PubMed ID: 29323005
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2.
    Klünemann HH; Ridha BH; Magy L; Wherrett JR; Hemelsoet DM; Keen RW; De Bleecker JL; Rossor MN; Marienhagen J; Klein HE; Peltonen L; Paloneva J
    Neurology; 2005 May; 64(9):1502-7. PubMed ID: 15883308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the
    Ghezzi L; Carandini T; Arighi A; Fenoglio C; Arcaro M; De Riz M; Pietroboni AM; Fumagalli GG; Basilico P; Calvi A; Scarioni M; Colombi A; Serpente M; Marotta G; Benti R; Scarpini E; Galimberti D
    Neurology; 2017 Dec; 89(24):2503-2505. PubMed ID: 29142083
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J
    Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous TREM2 c.549del; p.(Leu184Serfs*5) variant causing Nasu-Hakola disease in three siblings in a consanguineous Iraqi family: Case report and review of literature.
    Gilani N; Bitarafan F; Ozaslan M; Åsheim S; Heidari M; Garshasbi M
    Mol Genet Genomic Med; 2024 Jun; 12(6):e2476. PubMed ID: 38888203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms.
    Kondo T; Takahashi K; Kohara N; Takahashi Y; Hayashi S; Takahashi H; Matsuo H; Yamazaki M; Inoue K; Miyamoto K; Yamamura T
    Neurology; 2002 Oct; 59(7):1105-7. PubMed ID: 12370476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.
    Bianchin MM; Capella HM; Chaves DL; Steindel M; Grisard EC; Ganev GG; da Silva Júnior JP; Neto Evaldo S; Poffo MA; Walz R; Carlotti Júnior CG; Sakamoto AC
    Cell Mol Neurobiol; 2004 Feb; 24(1):1-24. PubMed ID: 15049507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological tests and functional nuclear neuroimaging provide evidence of subclinical impairment in Nasu-Hakola disease heterozygotes.
    Montalbetti L; Ratti MT; Greco B; Aprile C; Moglia A; Soragna D
    Funct Neurol; 2005; 20(2):71-5. PubMed ID: 15966270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.